Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


OLIENA
Language recovery after stroke
App | Video | PDF (278 pp) | Web

  Rheumatoid Arthritis

  Free Subscription


Articles published in Z Rheumatol

Retrieve available abstracts of 63 articles:
HTML format
Text format



Single Articles


    July 2018
  1. BAE SC, Lee YH
    Causal association between rheumatoid arthritis and a decreased risk of Alzheimer's disease : A Mendelian randomization study.
    Z Rheumatol. 2018 Jul 5. pii: 10.1007/s00393-018-0504.
    PubMed     Text format     Abstract available


  2. NEUMANN E, Frommer K, Diller M, Muller-Ladner U, et al
    [Rheumatoid arthritis].
    Z Rheumatol. 2018 Jul 5. pii: 10.1007/s00393-018-0500.
    PubMed     Text format     Abstract available


  3. FIEHN C, Holle J, Iking-Konert C, Leipe J, et al
    [S2e guideline: treatment of rheumatoid arthritis with disease-modifying drugs].
    Z Rheumatol. 2018 Jul 3. pii: 10.1007/s00393-018-0481.
    PubMed     Text format     Abstract available


    May 2018
  4. OSTOJIC P, Pavlov-Dolijanovic S
    Alopecia universalis in a patient with rheumatoid arthritis developed during treatment with adalimumab.
    Z Rheumatol. 2018 May 9. pii: 10.1007/s00393-018-0464.
    PubMed     Text format     Abstract available


    April 2018
  5. BAUHAMMER J, Fiehn C
    [Getting older with rheumatoid arthritis-is there a burnout of the disease?]
    Z Rheumatol. 2018 Apr 30. pii: 10.1007/s00393-018-0465.
    PubMed     Text format     Abstract available


  6. HAUPL T, Skapenko A, Hoppe B, Skriner K, et al
    [Biomarkers and imaging for diagnosis and stratification of rheumatoid arthritis and spondylarthritis in the BMBF consortium ArthroMark].
    Z Rheumatol. 2018 Apr 24. pii: 10.1007/s00393-018-0458.
    PubMed     Text format     Abstract available


  7. KUIPERS JG, Koller M, Zeman F, Muller K, et al
    Adherence and health literacy as related to outcome of patients treated for rheumatoid arthritis : Analyses of a large-scale observational study.
    Z Rheumatol. 2018 Apr 24. pii: 10.1007/s00393-018-0449.
    PubMed     Text format     Abstract available


  8. TURGAY YILDIRIM O, Gonullu E, Aydin F, Aksit E, et al
    Nocturnal blood pressure dipping is similar in rheumatoid arthritis patients as compared to a normal population.
    Z Rheumatol. 2018 Apr 12. pii: 10.1007/s00393-018-0451.
    PubMed     Text format     Abstract available


    February 2018
  9. LIU Y, Wen H
    Impact of vitamin D deficiency on clinical parameters in treatment-naive rheumatoid arthritis patients.
    Z Rheumatol. 2018 Feb 19. pii: 10.1007/s00393-018-0426.
    PubMed     Text format     Abstract available


    January 2018
  10. BAE SC, Lee YH
    TYMS polymorphisms and responsiveness to or toxicity of methotrexate in rheumatoid arthritis.
    Z Rheumatol. 2018 Jan 29. pii: 10.1007/s00393-018-0419.
    PubMed     Text format     Abstract available


    September 2017
  11. STRAHL A, Schneider O, Frankenhauser-Mannuss J, Knapstein S, et al
    [Prevalence, comorbidity and interdisciplinary treatment of rheumatoid arthritis - Insurance data on outpatient and inpatient care in Baden-Wurttemberg].
    Z Rheumatol. 2017 Sep 19. doi: 10.1007/s00393-017-0381.
    PubMed     Text format     Abstract available


  12. KOTHE R
    [Low back pain in rheumatoid arthritis].
    Z Rheumatol. 2017 Sep 5. doi: 10.1007/s00393-017-0363.
    PubMed     Text format     Abstract available


    August 2017
  13. KOTTER I, Stubiger N, Deuter C
    [Ocular involvement in rheumatoid arthritis, connective tissue diseases and vasculitis].
    Z Rheumatol. 2017 Aug 31. doi: 10.1007/s00393-017-0372.
    PubMed     Text format     Abstract available


  14. STROBEL S, Rossol M
    [Monocyte subpopulations in patients with rheumatoid arthritis].
    Z Rheumatol. 2017 Aug 3. doi: 10.1007/s00393-017-0352.
    PubMed     Text format    


    May 2017
  15. BAE SC, Lee YH
    Association between anti-Porphyromonas gingivalis antibody, anti-citrullinated protein antibodies, and rheumatoid arthritis : A meta-analysis.
    Z Rheumatol. 2017 May 29. doi: 10.1007/s00393-017-0328.
    PubMed     Text format     Abstract available


    April 2017
  16. KEYSSER G
    [Success for a new generation of disease-modifying antirheumatic drugs : The Janus kinase inhibitor baricitinib in rheumatoid arthritis].
    Z Rheumatol. 2017 Apr 26. doi: 10.1007/s00393-017-0307.
    PubMed     Text format    


  17. ALBRECHT K, Richter A, Meissner Y, Huscher D, et al
    [How frequent are poor prognostic markers in rheumatoid arthritis? : An estimate based on three epidemiologic cohorts].
    Z Rheumatol. 2017 Apr 20. doi: 10.1007/s00393-017-0306.
    PubMed     Text format     Abstract available


    March 2017
  18. ALBRECHT K, Luque Ramos A, Callhoff J, Hoffmann F, et al
    [Outpatient care and disease burden of rheumatoid arthritis : Results of a linkage of claims data and a survey of insured persons].
    Z Rheumatol. 2017 Mar 21. doi: 10.1007/s00393-017-0294.
    PubMed     Text format     Abstract available


  19. BAE SC, Lee YH
    Comparative efficacy and tolerability of sarilumab 150 and 200 mg in patients with active rheumatoid arthritis : A Bayesian network meta-analysis of randomized controlled trials.
    Z Rheumatol. 2017 Mar 21. doi: 10.1007/s00393-017-0292.
    PubMed     Text format     Abstract available


    January 2017
  20. SCHNEIDER M
    [New options for the practice : Update S1/S2 guidelines on rheumatoid arthritis?]
    Z Rheumatol. 2017 Jan 19. doi: 10.1007/s00393-016-0261.
    PubMed     Text format     Abstract available


  21. LEE YH, Bae SC
    Comparative efficacy and safety of baricitinib 2 mg and 4 mg in patients with active rheumatoid arthritis : A Bayesian network meta-analysis of randomized controlled trials.
    Z Rheumatol. 2017 Jan 17. doi: 10.1007/s00393-016-0254.
    PubMed     Text format     Abstract available


  22. WEBER S, Pongratz G, Schneider M, Brinks R, et al
    Need for improvements in reported cost effectiveness of adalimumab in rheumatoid arthritis.
    Z Rheumatol. 2017 Jan 13. doi: 10.1007/s00393-016-0255.
    PubMed     Text format    


  23. GISSEL C, Gotz G, Repp H
    Reply to: Need for improvements in reported cost-effectiveness of adalimumab in rheumatoid arthritis.
    Z Rheumatol. 2017 Jan 13. doi: 10.1007/s00393-016-0256.
    PubMed     Text format    


  24. ALETAHA D, Kerschbaumer A
    [Rheumatoid arthritis].
    Z Rheumatol. 2017 Jan 5. doi: 10.1007/s00393-016-0251.
    PubMed     Text format     Abstract available


    December 2016
  25. BES C, Gurel S, Bugdayci G, Dikbas O, et al
    Atherosclerosis assessment and rheumatoid arthritis.
    Z Rheumatol. 2016.
    PubMed     Text format     Abstract available


    November 2016
  26. FADDA SM, Bassyouni IH, Khalifa RH, Elsaid NY, et al
    Pleiotrophin, the angiogenic and mitogenic growth factor: levels in serum and synovial fluid in rheumatoid arthritis and osteoarthritis : And correlation with clinical, laboratory and radiological indices.
    Z Rheumatol. 2016.
    PubMed     Text format     Abstract available


  27. WANG X, Yan X, Wang F, Ge F, et al
    Role of methotrexate chronotherapy in collagen-induced rheumatoid arthritis in rats.
    Z Rheumatol. 2016.
    PubMed     Text format     Abstract available


  28. LEE YH, Bae SC
    Correlation between circulating VEGF levels and disease activity in rheumatoid arthritis: a meta-analysis.
    Z Rheumatol. 2016.
    PubMed     Text format     Abstract available


    September 2016
  29. LEE YH, Bae SC
    Association between shortened telomere length and rheumatoid arthritis : A meta-analysis.
    Z Rheumatol. 2016.
    PubMed     Text format     Abstract available


  30. ZENGIN O, Onder ME, Kalem A, Bilici M, et al
    New inflammatory markers in early rheumatoid arthritis.
    Z Rheumatol. 2016.
    PubMed     Text format     Abstract available


    August 2016
  31. YANG XK, Li P, Zhang C, Leng RX, et al
    Association between IRAK1 rs3027898 and miRNA-499 rs3746444 polymorphisms and rheumatoid arthritis : A case control study and meta-analysis.
    Z Rheumatol. 2016.
    PubMed     Text format     Abstract available


  32. PATTLOCH D, Richter A, Manger B, Dockhorn R, et al
    [The first biologic for rheumatoid arthritis: factors influencing the therapeutic decision].
    Z Rheumatol. 2016.
    PubMed     Text format     Abstract available


    July 2016
  33. LEE YH, Bae SC
    Associations between eNOS polymorphisms and susceptibility to systemic lupus erythematosus and rheumatoid arthritis: a meta-analysis.
    Z Rheumatol. 2016.
    PubMed     Text format     Abstract available


  34. HARRE U, Schett G
    [Association between bone catabolism and anti-citrullinated protein antibodies in rheumatoid arthritis].
    Z Rheumatol. 2016.
    PubMed     Text format     Abstract available


  35. KLEIN K, Gay RE, Gay S
    [Synovial fibroblasts : Main players in rheumatoid arthritis].
    Z Rheumatol. 2016.
    PubMed     Text format    


  36. ALBRECHT K, Huscher D, Eidner T, Kleinert S, et al
    [Medical treatment of rheumatoid arthritis in 2014 : Current data from the German Collaborative Arthritis Centers].
    Z Rheumatol. 2016.
    PubMed     Text format     Abstract available


    June 2016
  37. LEE YH, Bae SC
    Efficacy and safety of methotrexate plus certolizumab pegol or placebo in active rheumatoid arthritis : Meta-analysis of randomized controlled trials.
    Z Rheumatol. 2016.
    PubMed     Text format     Abstract available


  38. LEE YH, Bae SC
    Diagnostic accuracy of anti-Sa and anti-RA33 antibodies in rheumatoid arthritis: a meta-analysis.
    Z Rheumatol. 2016.
    PubMed     Text format     Abstract available


    May 2016
  39. BRAUN J, Krause A, Aringer M, Burmester G, et al
    [Standards of care for people with rheumatoid arthritis in Europe : Translation and comments of the eumusc.net recommendations supported by EULAR performed by a national task force of the professional organisations DGRh and VRA supported by "Deutsche
    Z Rheumatol. 2016.
    PubMed     Text format     Abstract available


    April 2016
  40. HENSE S, Luque Ramos A, Callhoff J, Albrecht K, et al
    [Prevalence of rheumatoid arthritis in Germany based on health insurance data : Regional differences and first results of the PROCLAIR study].
    Z Rheumatol. 2016.
    PubMed     Text format     Abstract available


  41. GISSEL C, Gotz G, Repp H
    Cost-effectiveness of adalimumab for rheumatoid arthritis in Germany.
    Z Rheumatol. 2016.
    PubMed     Text format     Abstract available


    March 2016
  42. BRAUN J, Bessler F, Lakomek HJ, Rudwaleit M, et al
    [International quality indicators in rheumatology : Suggestions for rheumatoid arthritis].
    Z Rheumatol. 2016.
    PubMed     Text format     Abstract available


  43. BRAUN J, Schneider M, Lakomek HJ
    [Cornerstones of quality assurance in medicine in Germany. Important impulse for the situation in treatment of rheumatism].
    Z Rheumatol. 2016;75:203-12.
    PubMed     Text format     Abstract available


    February 2016
  44. SPRINGORUM HR, Winkler S, Maderbacher G, Gotz J, et al
    [Operative therapy for rheumatoid arthritis of the hand].
    Z Rheumatol. 2016.
    PubMed     Text format     Abstract available


  45. RUBBERT-ROTH A, Zander T, Kneitz C, Baerwald C, et al
    [Lung cancer and rheumatoid arthritis : An interdisciplinary challenge].
    Z Rheumatol. 2016.
    PubMed     Text format     Abstract available


  46. BURKHARDT H, Weisenseel P, Radtke MA, Kruger K, et al
    [Malignancies of the skin and immunomodulatory antirheumatic therapy].
    Z Rheumatol. 2016;75:32-40.
    PubMed     Text format     Abstract available


  47. TONY HP
    [Rheumatism and cancer].
    Z Rheumatol. 2016;75:11-2.
    PubMed     Text format    


    January 2016
  48. LEE YH, Bae SC
    Circulating leptin level in rheumatoid arthritis and its correlation with disease activity: a meta-analysis.
    Z Rheumatol. 2016.
    PubMed     Text format     Abstract available


  49. WALDNER MJ, Strangfeld A, Aringer M
    [Influence of therapy on risk of cancer in rheumatoid arthritis : Pathophysiological principles].
    Z Rheumatol. 2016.
    PubMed     Text format     Abstract available


  50. KLEINERT S, Waldner M, Wendler J, Kunzmann V, et al
    [Disease-modifying antirheumatic drugs in rheumatoid arthritis patients with a history of colorectal cancer].
    Z Rheumatol. 2016.
    PubMed     Text format     Abstract available


  51. BOEGEMANN M, Alten R, Aringer M, Zastrow S, et al
    [Genitourinary malignancies and rheumatoid arthritis].
    Z Rheumatol. 2016.
    PubMed     Text format     Abstract available


  52. SCHMALZING M, Strangfeld A, Tony HP
    [Medication treatment of rheumatoid arthritis with a history of malignancy : Epidemiological data].
    Z Rheumatol. 2016.
    PubMed     Text format     Abstract available


    December 2015
  53. EL DEFRAWY AO, Gheita TA, Raslan HM, El Ansary MM, et al
    Serum and synovial cartilage oligomeric matrix protein levels in early and established rheumatoid arthritis.
    Z Rheumatol. 2015.
    PubMed     Text format     Abstract available


  54. ALBRECHT K, Callhoff J, Edelmann E, Schett G, et al
    [Clinical remission in rheumatoid arthritis : Data from the early arthritis cohort study CAPEA].
    Z Rheumatol. 2015.
    PubMed     Text format     Abstract available


    June 2015
  55. RUBBERT-ROTH A
    [Switching within the active ingredient group or changing the mechanism of action. Data situation by failure of the first line biologic].
    Z Rheumatol. 2015;74:406-13.
    PubMed     Text format     Abstract available


    May 2015

  56. [How does periodontitis have an impact on RA].
    Z Rheumatol. 2015;74:283.
    PubMed     Text format    



  57. [Risk of infection among biologics].
    Z Rheumatol. 2015;74:282.
    PubMed     Text format    


  58. LEE YH, Bae SC, Kim JH, Seo YH, et al
    Meta-analysis of SLC22A4 and RUNX1 polymorphisms : Associations with rheumatoid arthritis susceptibility.
    Z Rheumatol. 2015;74:351-8.
    PubMed     Text format     Abstract available


    March 2015
  59. STRANGFELD A, Richter A
    [How do register data support clinical decision-making?].
    Z Rheumatol. 2015;74:119-24.
    PubMed     Text format     Abstract available


    February 2015
  60. KALDEN JR
    [Pathogenic cells of rheumatic inflammation as the target of modern therapies].
    Z Rheumatol. 2015;74:8-13.
    PubMed     Text format     Abstract available


  61. HIEPE F, Alexander T, Voll RE
    [Plasma cells].
    Z Rheumatol. 2015;74:20-5.
    PubMed     Text format     Abstract available


  62. LEIPE J, Chang HD
    [Effector T cells].
    Z Rheumatol. 2015;74:14-9.
    PubMed     Text format     Abstract available


  63. LEIPE J
    [Interleukin-22 - friend or foe?].
    Z Rheumatol. 2015;74:51-3.
    PubMed     Text format    


Thank you for your interest in scientific medicine.


AMEDEO Rheumatoid Arthritis is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: